WallStreetZenWallStreetZen

NASDAQ: TARA
Protara Therapeutics Inc Stock Ownership - Who owns Protara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Protara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jesse SheffermanCEO and President2026-06-29215,687$1.91
$411.96kBuy
Jesse SheffermanCEO and President2026-06-29215,687$4.09
$882.16kSell
William ConklingChief Commercial Officer2026-06-026,008$4.34
$26.07kSell
Jacqueline ZummoChief RD Officer2026-04-081,134$5.40
$6.12kSell
Jacqueline ZummoChief RD Officer2026-04-0122,598$5.26
$118.87kSell
Jesse SheffermanCEO and President2026-01-268,732$6.67
$58.24kSell
Hannah FryVP Controller2026-01-261,457$6.67
$9.72kSell
Patrick FabbioChief Financial Officer2026-01-263,261$6.67
$21.75kSell
Jacqueline ZummoChf Scientific Operations Off2026-01-263,724$6.67
$24.84kSell
Jacqueline ZummoChf Scientific Operations Off2026-01-206,578$5.60
$36.84kSell

1 of 2

TARA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARA insiders and whales buy or sell their stock.

TARA Shareholders

What type of owners hold Protara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hubert Birner9.53%5,632,802$13.97MInsider
Abingworth LLP7.04%4,162,389$10.32MInsider
Tvm Life Science Ventures VI Gmbh Co Kg6.51%3,846,186$9.54MInsider
John Gordon Freund6.11%3,608,812$8.95MInsider
James E. Flynn4.10%2,422,745$6.01MInsider
Timothy Haines3.63%2,144,517$5.32MInsider
Opaleye Management Inc3.37%1,989,134$4.93MInsider
Skyline Venture Partners Qualified Purchaser Fund IV L P2.42%1,432,930$3.55MInsider
Brendan Oleary2.35%1,387,198$3.44MInsider
International Sa Pharmstandard1.97%1,165,344$2.89MInsider

1 of 3

TARA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARA0.08%53.58%Net Selling
PRQR0.06%2.28%Net Buying
MENS0.00%33.35%
NGEN0.01%0.00%
CUE0.02%91.77%Net BuyingNet Selling
View Top Biotech Stocks

Protara Therapeutics Stock Ownership FAQ

Who owns Protara Therapeutics?

Protara Therapeutics (NASDAQ: TARA) is owned by 0.08% institutional shareholders, 53.58% Protara Therapeutics insiders, and 46.34% retail investors. Hubert Birner is the largest individual Protara Therapeutics shareholder, owning 5.63M shares representing 9.53% of the company. Hubert Birner's Protara Therapeutics shares are currently valued at $13.58M.

If you're new to stock investing, here's how to buy Protara Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.